1. A composite prognostic model for overall survival (OS) based on residual cancer burden (RCB) and tumor-infiltrating lymphocytes (TILs) on residual disease (RCB+TIL) in HER2+ breast cancer patients treated with neoadjuvant therapy: a multicenter study. (November 2022) Authors: Miglietta, F.; Ragazzi, M.; Fernandes, B.; Griguolo, G.; Massa, D.; Bisagni, A.; Bottosso, M.; Porra, F.; Gaudio, M.; Iannaccone, D.; Fassan, M.; Lo Mele, M.; Gasparini, E.; Zarrilli, G.; Coiro, S.; Dore, L.; Zambelli, A.; Bisagni, G.; Guarneri, V.; Dieci, M.V. Journal: European journal of cancer Issue: Volume 175(2022)Supplement 1 Page Start: S3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. BMI is an independent prognostic factor for late outcome in patients diagnosed with early breast cancer: A landmark survival analysis. (April 2018) Authors: Vernaci, G.; Dieci, M.V.; Gaia, G.; Miglietta, F.; Manfrin, S.; Saibene, T.; Silvia, M.; Ghiotto, C.; Pierfranco, C.; Guarneri, V. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 3 Page Start: S42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Characterization of baseline factors associated with treatment outcome in HCV-infected patients naive to direct acting antivirals: particular focus on natural resistance. (February 2019) Authors: Barbaliscia, S.; Di Maio, V.C.; Teti, E.; Aragri, M.; Paolucci, S.; Masetti, C.; D'Ambrosio, R.; Degasperi, E.; Polilli, E.; Palitti, V. Pace; Fiorentino, G.; Foroghi, L.; Cento, V.; Scutari, R.; Bruzzone, B.; Calvaruso, V.; Coppola, N.; Gaeta, G.B.; Morsica, G.; Ghisetti, V. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Chemotherapy for advanced HER2-negative breast cancer: Can one algorithm fit all?. (November 2017) Authors: Miglietta, F.; Dieci, M.V.; Griguolo, G.; Guarneri, V.; Conte, P.F. Journal: Cancer treatment reviews Issue: Volume 60(2017) Page Start: 100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Fat grafting for breast cancer patients: From basic science to clinical studies. Issue 8 (August 2016) Authors: Gennari, R.; Griguolo, G.; Dieci, M.V.; Guarneri, V.; Tavaniello, B.; Sibilio, A.; Conte, P. Journal: European journal of surgical oncology Issue: Volume 42:Issue 8(2016:Aug.) Page Start: 1088 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Hepatitis C core antigen assay for the monitoring of treatment with direct antiviral agents in patients with chronic Hepatitis C. (10th February 2016) Authors: Loggi, E.; Cursaro, C.; Scuteri, A.; Vukotic, R.; Grandini, E.; Margotti, M.; Guarneri, V.; Stanzani, M.; Galli, S.; Furlini, G.; Galli, C.; Landini, M.P.; Andreone, P. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 1 Page Start: e61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Immunotherapy in small-cell lung cancer: from molecular promises to clinical challenges. Issue 1 (5th August 2019) Authors: Pavan, A.; Attili, I.; Pasello, G.; Guarneri, V.; Conte, P. F.; Bonanno, L. Journal: Journal for immunotherapy of cancer Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Metronomic Temozolomide in Heavily Pretreated Patients With Recurrent Isocitrate Dehydrogenase Wild-type Glioblastoma: A Large Real-Life Mono-Institutional Study. Issue 5 (May 2023) Authors: Bosio, A.; Cerretti, G.; Padovan, M.; Caccese, M.; Denaro, L.; Chioffi, F.; Della Puppa, A.; Aldegheri, V.; Guarneri, V.; Zagonel, V.; Lombardi, G. Journal: Clinical oncology Issue: Volume 35:Issue 5(2023) Page Start: e319 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review. (March 2023) Authors: Miglietta, F.; Fabi, A.; Generali, D.; Dieci, M.V.; Arpino, G.; Bianchini, G.; Cinieri, S.; Conte, P.F.; Curigliano, G.; De Laurentis, M.; Del Mastro, L.; De Placido, S.; Gennari, A.; Puglisi, F.; Zambelli, A.; Perrone, F.; Guarneri, V. Journal: Cancer treatment reviews Issue: Volume 114(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Residual Risk of Relapse: a Systematic Review and a Consensus Project on Unmet needs for HER2-positive non Metastatic Breast Cancer Patients. (November 2022) Authors: Miglietta, F.; Pronzato, P.; Girardi, F.; Griguolo, G.; Guarneri, V.; Pappagallo, G.; Conte, P. Journal: European journal of cancer Issue: Volume 175(2022)Supplement 1 Page Start: S57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗